Thermo Fisher to launch new qPCR system

By staff writers

March 25, 2021 -- Thermo Fisher Scientific announced it has completed a U.S. Food and Drug Administration listing to launch its Applied Biosystems QuantStudio 5 Dx real-time polymerase chain reaction (qPCR) system. The new system simplifies molecular diagnostic workflows for infectious disease, oncology, and COVID-19 testing, according to the company.

Clinical diagnostic and hospital laboratories across the U.S. have ramped up PCR testing over the last year in response to the global COVID-19 pandemic. These laboratories are now seeking solutions to continue to screen for COVID-19 after emergency use authorizations (EUAs) for SARS-CoV-2 assays expire.

Thermo Fisher's new PCR system includes a simplified, efficient workflow that minimizes steps to deliver quality results in as little as 30 minutes and it comes in a compact footprint that can fit in any lab, the company said in a statement.

Copyright © 2021

To read this and get access to all of the exclusive content on, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?